Transcriptional regulation of tenascin genes

Cell Adhesion and Migration

Volumn 9, Issue 1-2, 2015, Pages 34-47

  Chiovaro, Francesca ^a,b   Chiquet Ehrismann, Ruth ^a,b   Chiquet, Matthias ^c  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cancer; Cytokine; Development; Extracellular matrix; Gene promoter; Gene regulation; Glucocorticoid; Growth factor; Homeobox gene; Matricellular; Mechanical stress; Tenascin; Transcription factor

Indexed keywords

FIBROBLAST GROWTH FACTOR; MICRORNA; PLATELET DERIVED GROWTH FACTOR; TENASCIN; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR SOX4; TRANSFORMING GROWTH FACTOR BETA; TENASCIN R; TENASCIN X;

ACUTE MEGAKARYOCYTIC LEUKEMIA; CARCINOGENESIS; CELL ADHESION; EXTRACELLULAR MATRIX; GENE; GENE DELETION; GENE SEQUENCE; HUMAN; INFLAMMATION; MECHANICAL STRESS; NERVE CELL DIFFERENTIATION; NONHUMAN; ORGANOGENESIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; TISSUE REPAIR; TNC GENE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; ANIMAL; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION; TENASCIN;

EID: 84954538694     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.1080/19336918.2015.1008333     Document Type: Review

References (150)

1. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol 2003; 200:488-99; http://dx.doi.org/10.1002/path.1415
2. Tucker RP, Chiquet-Ehrismann R. Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int J Biochem Cell Biol 2009; 41:424-34; http://dx.doi.org/10.1016/j.biocel.2008.08.003
3. Adams JC, Chiquet-Ehrismann R, Tucker RP. The evolution of tenascins and fibronectins. Cell Adh Migr 2014 Oct; 30:1-12
4. Murphy-Ullrich JE, Sage EH. Revisiting the matricellular concept. Matrix Biol 2014; 37:1-14; http://dx.doi.org/10.1016/j.matbio.2014.07.005
5. Chiquet-Ehrismann R, Tucker RP. Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol 2011; 3:a004960
6. Erickson HP. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5:869-76; http://dx.doi.org/10.1016/0955-0674(93)90037-Q
7. Chiquet-Ehrismann R. Tenascins, a growing family of extracellular matrix proteins. Experientia 1995; 51:853-62; http://dx.doi.org/10.1007/BF01921736
8. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 2000; 218:235-59; http://dx.doi.org/10.1002/(SICI)1097-0177(200006)218:2% 3c235::AID-DVDY2%3e3.0.CO;2-G
9. Martina E, Chiquet-Ehrismann R, Brellier F. Tenascin-W: an extracellular matrix protein associated with osteogenesis and cancer. Int J Biochem Cell Biol 2010; 42:1412-5; http://dx.doi.org/10.1016/j.biocel.2010.06.004
10. Joester A, Faissner A. The structure and function of tenascins in the nervous system. Matrix Biol 2001; 20:13-22; http://dx.doi.org/10.1016/S0945-053X(00)00136-0
11. Guttery DS, Shaw JA, Lloyd K, Pringle JH, Walker RA. Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev 2010; 29:595-606; http://dx.doi.org/10.1007/s10555-010-9249-9
12. Orend G. Potential oncogenic action of tenascin-C in tumorigenesis. Int J Biochem Cell Biol 2005; 37:1066-83; http://dx.doi.org/10.1016/j.biocel.2004.12.002
13. Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 2009; 1793:888-92; http://dx.doi.org/10.1016/j.bbamcr.2008.12.012
14. Mackie EJ, Tucker RP. The tenascin-C knockout revisited. J Cell Sci 1999; 112 (Pt 22):3847-53
15. Midwood KS, Hussenet T, Langlois B, Orend G. Advances in tenascin-C biology. Cell Mol Life Sci 2011; 68:3175-99; http://dx.doi.org/10.1007/s00018-011-0783-6
16. Anlar B, Gunel-Ozcan A. Tenascin-R: role in the central nervous system. Int J Biochem Cell Biol 2012; 44:1385-9; http://dx.doi.org/10.1016/j.biocel.2012.05.009
17. O’Connell M, Burrows NP, van Vlijmen-Willems MJ, Clark SM, Schalkwijk J. Tenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature. Br J Dermatol 2010; 163:1340-5; http://dx.doi.org/10.1111/j.1365-2133.2010.09949.x
18. Matsumoto K, Saga Y, Ikemura T, Sakakura T, Chiquet-Ehrismann R. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 1994; 125:483-93; http://dx.doi.org/10.1083/jcb.125.2.483
19. Brellier F, Martina E, Degen M, Heuze-Vourc’h N, Petit A, Kryza T, Courty Y, Terracciano L, Ruiz C, Chiquet-Ehrismann R. Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors. BMC Clin Pathol 2012; 12:14; http://dx.doi.org/10.1186/1472-6890-12-14
20. Gherzi R, Carnemolla B, Siri A, Ponassi M, Balza E, Zardi L. Human tenascin gene. Structure of the 50-region, identification, and characterization of the transcription regulatory sequences. J Biol Chem 1995; 270:3429-34; http://dx.doi.org/10.1074/jbc.270.7.3429
21. Sriramarao P, Bourdon MA. A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res 1993; 21:163-8; http://dx.doi.org/10.1093/nar/21.1.163
22. Mighell AJ, Thompson J, Hume WJ, Markham AF, Robinson PA. Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae. Int J Cancer 1997; 72:236-40; http://dx.doi.org/10.1002/(SICI)1097-0215(19970717)72:2%3c236::AID-IJC6%3e3.0.CO;2-S
23. Copertino DW, Jenkinson S, Jones FS, Edelman GM. Structural and functional similarities between the promoters for mouse tenascin and chicken cytotactin. Proc Natl Acad Sci U S A 1995; 92:2131-5; http://dx.doi.org/10.1073/pnas.92.6.2131
24. Jones FS, Crossin KL, Cunningham BA, Edelman GM. Identification and characterization of the promoter for the cytotactin gene. Proc Natl Acad Sci U S A 1990; 87:6497-501; http://dx.doi.org/10.1073/pnas.87.17.6497
25. Jones PL, Jones FS. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 2000; 19:581-96; http://dx.doi.org/10.1016/S0945-053X(00)00106-2
26. Chiquet M, Fambrough DM. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol 1984; 98:1926-36; http://dx.doi.org/10.1083/jcb.98.6.1926
27. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47:131-9; http://dx.doi.org/10.1016/0092-8674(86)90374-0
28. Mackie EJ, Tucker RP, Halfter W, Chiquet-Ehrismann R, Epperlein HH. The distribution of tenascin coincides with pathways of neural crest cell migration. Development 1988; 102:237-50
29. Tucker RP, McKay SE. The expression of tenascin by neural crest cells and glia. Development 1991; 112:1031-9
30. Wehrle B, Chiquet M. Tenascin is accumulated along developing peripheral nerves and allows neurite outgrowth in vitro. Development 1990; 110:401-15
31. Imanaka-Yoshida K, Aoki H. Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Front Physiol 2014; 5:283; http://dx.doi.org/10.3389/fphys.2014.00283
32. Inaguma Y, Kusakabe M, Mackie EJ, Pearson CA, Chiquet-Ehrismann R, Sakakura T. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol 1988; 128:245-55; http://dx.doi.org/10.1016/0012-1606(88)90288-6
33. Thesleff I, Mackie E, Vainio S, Chiquet-Ehrismann R. Changes in the distribution of tenascin during tooth development. Development 1987; 101:289-96
34. Aufderheide E, Chiquet-Ehrismann R, Ekblom P. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 1987; 105:599-608; http://dx.doi.org/10.1083/jcb.105.1.599
35. Koch M, Wehrle-Haller B, Baumgartner S, Spring J, Brubacher D, Chiquet M. Epithelial synthesis of tenascin at tips of growing bronchi and graded accumulation in basement membrane and mesenchyme. Exp Cell Res 1991; 194:297-300; http://dx.doi.org/10.1016/0014-4827(91)90368-5
36. Jones FS, Chalepakis G, Gruss P, Edelman GM. Activation of the cytotactin promoter by the homeoboxcontaining gene Evx-1. Proc Natl Acad Sci U S A 1992; 89:2091-5; http://dx.doi.org/10.1073/pnas.89.6.2091
37. Briata P, Ilengo C, Bobola N, Corte G. Binding properties of the human homeodomain protein OTX2 to a DNA target sequence. FEBS Lett 1999; 445:160-4; http://dx.doi.org/10.1016/S0014-5793(99)00113-1
38. Gherzi R, Briata P, Boncinelli E, Ponassi M, Querze G, Viti F, Corte G, Zardi L. The human homeodomain protein OTX2 binds to the human tenascin-C promoter and trans-represses its activity in transfected cells. DNA Cell Biol 1997; 16:559-67; http://dx.doi.org/10.1089/dna.1997.16.559
39. Copertino DW, Edelman GM, Jones FS. Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. Proc Natl Acad Sci U S A 1997; 94:1846-51; http://dx.doi.org/10.1073/pnas.94.5.1846
40. Martin JF, Bradley A, Olson EN. The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev 1995; 9:1237-49; http://dx.doi.org/10.1101/gad.9.10.1237
41. Kawanami A, Matsushita T, Chan YY, Murakami S. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem Biophys Res Commun 2009; 386:477-82; http://dx.doi.org/10.1016/j.bbrc.2009.06.059
42. Jones FS, Meech R, Edelman DB, Oakey RJ, Jones PL. Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease. Circ Res 2001; 89:131-8; http://dx.doi.org/10.1161/hh1401.093582
43. Ihida-Stansbury K, McKean DM, Gebb SA, Martin JF, Stevens T, Nemenoff R, Akeson A, Vaughn J, Jones PL. Paired-related homeobox gene Prx1 is required for pulmonary vascular development. Circ Res 2004; 94:1507-14; http://dx.doi.org/10.1161/01.RES.0000130656.72424.20
44. Ihida-Stansbury K, McKean DM, Lane KB, Loyd JE, Wheeler LA, Morrell NW, Jones PL. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2006; 291:L694-702; http://dx.doi.org/10.1152/ajplung.00119.2006
45. Murchison ND, Price BA, Conner DA, Keene DR, Olson EN, Tabin CJ, Schweitzer R. Regulation of tendon differentiation by scleraxis distinguishes forcetransmitting tendons from muscle-anchoring tendons. Development 2007; 134:2697-708; http://dx.doi.org/10.1242/dev.001933
46. della Gaspera B, Armand AS, Sequeira I, Lecolle S, Gallien CL, Charbonnier F, Chanoine C. The Xenopus MEF2 gene family: evidence of a role for XMEF2C in larval tendon development. Dev Biol 2009; 328:392-402; http://dx.doi.org/10.1016/j.ydbio.2009.01.039
47. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, Weller A, Bühler FR. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 1992; 141:377-88
48. Fluck M, Tunc-Civelek V, Chiquet M. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J Cell Sci 2000; 113 (Pt 20):3583-91
49. Fluck M, Chiquet M, Schmutz S, Mayet-Sornay MH, Desplanches D. Reloading of atrophied rat soleus muscle induces tenascin-C expression around damaged muscle fibers. Am J Physiol Regul Integr Comp Physiol 2003; 284:R792-801
50. Crameri RM, Langberg H, Teisner B, Magnusson P, Schroder HD, Olesen JL, Jensen CH, Koskinen S, Suetta C, Kjaer M. Enhanced procollagen processing in skeletal muscle after a single bout of eccentric loading in humans. Matrix Biol 2004; 23:259-64; http://dx.doi.org/10.1016/j.matbio.2004.05.009
51. Shyy JY, Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol 1997; 9:707-13; http://dx.doi.org/10.1016/S0955-0674(97)80125-1
52. Sarasa-Renedo A, Chiquet M. Mechanical signals regulating extracellular matrix gene expression in fibroblasts. Scand J Med Sci Sports 2005; 15:223-30; http://dx.doi.org/10.1111/j.1600-0838.2005.00461.x
53. Chiquet M, Sarasa-Renedo A, Tunc-Civelek V. Induction of tenascin-C by cyclic tensile strain versus growth factors: distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim Biophys Acta 2004; 1693:193-204; http://dx.doi.org/10.1016/j.bbamcr.2004.08.001
54. Lutz R, Sakai T, Chiquet M. Pericellular fibronectin is required for RhoA-dependent responses to cyclic strain in fibroblasts. J Cell Sci 2010; 123:1511-21; http://dx.doi.org/10.1242/jcs.060905
55. Maier S, Lutz R, Gelman L, Sarasa-Renedo A, Schenk S, Grashoff C, Chiquet M. Tenascin-C induction by cyclic strain requires integrin-linked kinase. Biochim Biophys Acta 2008; 1783:1150-62; http://dx.doi.org/10.1016/j.bbamcr.2008.01.013
56. Sarasa-Renedo A, Tunc-Civelek V, Chiquet M. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain. Exp Cell Res 2006; 312:1361-70; http://dx.doi.org/10.1016/j.yexcr.2005.12.025
57. Asparuhova MB, Gelman L, Chiquet M. Role of the actin cytoskeleton in tuning cellular responses to external mechanical stress. Scand J Med Sci Sports 2009; 19:490-9; http://dx.doi.org/10.1111/j.1600-0838.2009.00928.x
58. Asparuhova MB, Ferralli J, Chiquet M, Chiquet-Ehrismann R. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factorindependent activation of tenascin-C transcription by mechanical stress. FASEB J 2011; 25:3477-88; http://dx.doi.org/10.1096/fj.11-187310
59. Gurbuz I, Ferralli J, Roloff T, Chiquet-Ehrismann R, Asparuhova MB. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients. Mol Cancer 2014; 13:22; http://dx.doi.org/10.1186/1476-4598-13-22
60. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003; 113:329-42; http://dx.doi.org/10.1016/S0092-8674(03)00278-2
61. Scherer C, Pfisterer L, Wagner AH, Hodebeck M, Cattaruzza M, Hecker M, Korff T. Arterial wall stress controls NFAT5 activity in vascular smooth muscle cells. J Am Heart Assoc 2014; 3:e000626; http://dx.doi.org/10.1161/JAHA.113.000626
62. Yamamoto K, Dang QN, Kennedy SP, Osathanondh R, Kelly RA, Lee RT. Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species. J Biol Chem 1999; 274:21840-6; http://dx.doi.org/10.1074/jbc.274.31.21840
63. Chiquet-Ehrismann R, Tannheimer M, Koch M, Brunner A, Spring J, Martin D, Baumgartner S, Chiquet M. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol 1994; 127:2093-101; http://dx.doi.org/10.1083/jcb.127.6.2093
64. Chiquet M, Matthisson M, Koch M, Tannheimer M, Chiquet-Ehrismann R. Regulation of extracellular matrix synthesis by mechanical stress. Biochem Cell Biol 1996; 74:737-44; http://dx.doi.org/10.1139/o96-080
65. Khachigian LM, Resnick N, Gimbrone MA, Jr., Collins T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shearstress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995; 96:1169-75; http://dx.doi.org/10.1172/JCI118106
66. Chiquet-Ehrismann R, Orend G, Chiquet M, Tucker RP, Midwood KS. Tenascins in stem cell niches. Matrix Biol 2014.
67. Maqbool A, Hemmings KE, O’Regan DJ, Ball SG, Porter KE, Turner NA. Interleukin-1 has opposing effects on connective tissue growth factor and tenascin-C expression in human cardiac fibroblasts. Matrix Biol 2013; 32:208-14; http://dx.doi.org/10.1016/j.matbio.2013.02.003
68. Chevillard G, Derjuga A, Devost D, Zingg HH, Blank V. Identification of interleukin-1beta regulated genes in uterine smooth muscle cells. Reproduction 2007; 134:811-22; http://dx.doi.org/10.1530/REP-07-0289
69. Gratchev A, Kzhyshkowska J, Utikal J, Goerdt S. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand J Immunol 2005; 61:10-7; http://dx.doi.org/10.1111/j.0300-9475.2005.01524.x
70. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. J Invest Dermatol 2006; 126:551-60; http://dx.doi.org/10.1038/sj.jid.5700090
71. Kasza A. IL-1 and EGF regulate expression of genes important in inflammation and cancer. Cytokine 2013; 62:22-33; http://dx.doi.org/10.1016/j.cyto.2013.02.007
72. Wojdasiewicz P, Poniatowski LA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm 2014; 2014:561459; http://dx.doi.org/10.1155/2014/561459
73. Schiller M, Javelaud D, Mauviel A. TGF-b-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004; 35:83-92; http://dx.doi.org/10.1016/j.jdermsci.2003.12.006
74. Gordon KJ, Blobe GC. Role of transforming growth factor-b superfamily signaling pathways in human disease. Biochim Biophys Acta 2008; 1782:197-228; http://dx.doi.org/10.1016/j.bbadis.2008.01.006
75. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-b. EMBO J 1988; 7:2977-82
76. Scherberich A, Tucker RP, Degen M, Brown-Luedi M, Andres AC, Chiquet-Ehrismann R. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-a induced expression in vitro. Oncogene 2005; 24:1525-32; http://dx.doi.org/10.1038/sj.onc.1208342
77. Wiese S, Karus M, Faissner A. Astrocytes as a source for extracellular matrix molecules and cytokines. Front Pharmacol 2012; 3:120; http://dx.doi.org/10.3389/fphar.2012.00120
78. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-b in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 2004; 23:1656-67; http://dx.doi.org/10.1038/sj.onc.1207064
79. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol 2006; 206:718-27; http://dx.doi.org/10.1002/jcp.20527
80. Nishioka T, Suzuki M, Onishi K, Takakura N, Inada H, Yoshida T, Hiroe M, Imanaka-Yoshida K. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol 2007; 49:261-8; http://dx.doi.org/10.1097/FJC.0b013e318033dfd4
81. Oppong E, Flink N, Cato AC. Molecular mechanisms of glucocorticoid action in mast cells. Mol Cell Endocrinol 2013; 380:119-26; http://dx.doi.org/10.1016/j.mce.2013.05.014
82. Ekblom M, Fassler R, Tomasini-Johansson B, Nilsson K, Ekblom P. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts. J Cell Biol 1993; 123:1037-45; http://dx.doi.org/10.1083/jcb.123.4.1037
83. Ghatnekar A, Trojanowska M. GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. Biochim Biophys Acta 2008; 1779:145-51; http://dx.doi.org/10.1016/j.bbagrm.2007.11.012
84. Watanabe G, Nishimori H, Irifune H, Sasaki Y, Ishida S, Zembutsu H, Tanaka T, Kawaguchi S, Wada T, Hata J, et al. Induction of tenascin-C by tumorspecific EWS-ETS fusion genes. Genes Chromosomes Cancer 2003; 36:224-32; http://dx.doi.org/10.1002/gcc.10153
85. Mettouchi A, Cabon F, Montreau N, Dejong V, Vernier P, Gherzi R, Mercier G, Binetruy B. The c-Juninduced transformation process involves complex regulation of tenascin-C expression. Mol Cell Biol 1997; 17:3202-9
86. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 2009; 69:709-17; http://dx.doi.org/10.1158/0008-5472.CAN-08-3415
87. Mackie EJ, Chiquet-Ehrismann R, Pearson CA, Inaguma Y, Taya K, Kawarada Y, Sakakura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A 1987; 84:4621-5; http://dx.doi.org/10.1073/pnas.84.13.4621
88. Walker RA, Dearing SJ, Gallacher B. Relationship of transforming growth factor b 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 1994; 69:1160-5; http://dx.doi.org/10.1038/bjc.1994.228
89. Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell; 22:709-24; http://dx.doi.org/10.1016/j.ccr.2012.10.012
90. Wang MM. Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol 2011; 43:1550-62; http://dx.doi.org/10.1016/j.biocel.2011.08.005
91. Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J, Sundaresan T, Pastorino S, Park JK, Mikolaenko I, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005; 65:2353-63; http://dx.doi.org/10.1158/0008-5472.CAN-04-1890
92. Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, Ionescu MC, Zweifel C, Tolnay M, Wasner M, Mergenthaler S, et al. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res 2009; 69:458-65; http://dx.doi.org/10.1158/0008-5472.CAN-08-2610
93. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massague J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011; 17:867-74; http://dx.doi.org/10.1038/nm.2379
94. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-73; http://dx.doi.org/10.1038/nature03315
95. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; http://dx.doi.org/10.1016/S0092-8674(04)00045-5
96. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39:673-7; http://dx.doi.org/10.1038/ng2003
97. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-52; http://dx.doi.org/10.1038/nature06487
98. Leprini A, Gherzi R, Siri A, Querze G, Viti F, Zardi L. The human tenascin-R gene. J Biol Chem 1996; 271:31251-4; http://dx.doi.org/10.1074/jbc.271.49.31251
99. Gherzi R, Leprini A, Siri A, Zardi L. Structure of 5’ region of human tenascin-R gene and characterization of its promoter. DNA Cell Biol 1998; 17:275-82; http://dx.doi.org/10.1089/dna.1998.17.275
100. Leprini A, Gherzi R, Vecchi E, Borsi L, Zardi L, Siri A. Rat tenascin-R gene: structure, chromosome location and transcriptional activity of promoter and exon 1. Cytogenet Cell Genet 1998; 83:115-23; http://dx.doi.org/10.1159/000015146
101. Putthoff P, Akyuz N, Kutsche M, Zardi L, Borgmeyer U, Schachner M. Structure of the murine tenascin-R gene and functional characterisation of the promoter. Biochem Biophys Res Commun 2003; 308:940-9; http://dx.doi.org/10.1016/S0006-291X(03)01506-7
102. Derr LB, McKae LA, Tucker RP. The distribution of tenascin-R in the developing avian nervous system. J Exp Zool 1998; 280:152-64; http://dx.doi.org/10.1002/(SICI)1097-010X(19980201)280:2%3c152::AID-JEZ6%3e3.0.CO;2-N
103. Fuss B, Wintergerst ES, Bartsch U, Schachner M. Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160/180: a modular structure similar to tenascin. J Cell Biol 1993; 120:1237-49; http://dx.doi.org/10.1083/jcb.120.5.1237
104. Norenberg U, Wille H, Wolff JM, Frank R, Rathjen FG. The chicken neural extracellular matrix molecule restrictin: similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs. Neuron 1992; 8:849-63; http://dx.doi.org/10.1016/0896-6273(92)90199-N
105. Pesheva P, Gloor S, Schachner M, Probstmeier R. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism. J Neurosci 1997; 17:4642-51
106. Probstmeier R, Nellen J, Gloor S, Wernig A, Pesheva P. Tenascin-R is expressed by Schwann cells in the peripheral nervous system. J Neurosci Res 2001; 64:70-8; http://dx.doi.org/10.1002/jnr.1055
107. Pesheva P, Spiess E, Schachner M. J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J Cell Biol 1989; 109:1765-78; http://dx.doi.org/10.1083/jcb.109.4.1765
108. El Ayachi I, Fernandez C, Baeza N, De Paula AM, Pesheva P, Figarella-Branger D. Spatiotemporal distribution of tenascin-R in the developing human cerebral cortex parallels neuronal migration. J Comp Neurol 2011; 519:2379-89; http://dx.doi.org/10.1002/cne.22632
109. Morganti MC, Taylor J, Pesheva P, Schachner M. Oligodendrocyte-derived J1-160/180 extracellular matrix glycoproteins are adhesive or repulsive depending on the partner cell type and time of interaction. Exp Neurol 1990; 109:98-110; http://dx.doi.org/10.1016/S0014-4886(05)80012-3
110. Pesheva P, Probstmeier R. The yin and yang of tenascin-R in CNS development and pathology. Prog Neurobiol 2000; 61:465-93; http://dx.doi.org/10.1016/S0301-0082(99)00061-1
111. Angelov DN, Walther M, Streppel M, Guntinas-Lichius O, Neiss WF, Probstmeier R, Pesheva P. Tenascin-R is antiadhesive for activated microglia that induce downregulation of the protein after peripheral nerve injury: a new role in neuronal protection. J Neurosci 1998; 18:6218-29
112. Lang DM, Monzon-Mayor M, Del Mar Romero-Aleman M, Yanes C, Santos E, Pesheva P. Tenascin-R and axon growth-promoting molecules are up-regulated in the regenerating visual pathway of the lizard (Gallotia galloti). Dev Neurobiol 2008; 68:899-916; http://dx.doi.org/10.1002/dneu.20624
113. El Ayachi I, Baeza N, Fernandez C, Colin C, Scavarda D, Pesheva P, Figarella-Branger D. KIAA0510, the 3’-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas. Neuropathol Appl Neurobiol 2010; 36:399-410; http://dx.doi.org/10.1111/j.1365-2990.2010.01074.x
114. Jung M, Pesheva P, Schachner M, Trotter J. Astrocytes and neurons regulate the expression of the neural recognition molecule janusin by cultured oligodendrocytes. Glia 1993; 9:163-75; http://dx.doi.org/10.1002/glia.440090302
115. Morel Y, Bristow J, Gitelman SE, Miller WL. Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc Natl Acad Sci U S A 1989; 86: 6582-6; http://dx.doi.org/10.1073/pnas.86.17.6582
116. Bristow J, Carey W, Egging D, Schalkwijk J. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 2005; 139C:24-30; http://dx.doi.org/10.1002/ajmg.c.30071
117. Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 1993; 122:265-78; http://dx.doi.org/10.1083/jcb.122.1.265
118. Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, van Haren B, Miller WL, Bristow J. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001; 345:1167-75; http://dx.doi.org/10.1056/NEJMoa002939
119. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 1997; 17:104-8; http://dx.doi.org/10.1038/ng0997-104
120. Speek M, Barry F, Miller WL. Alternate promoters and alternate splicing of human tenascin-X, a gene with 5’ and 3’ ends buried in other genes. Hum Mol Genet 1996; 5:1749-58; http://dx.doi.org/10.1093/hmg/5.11.1749
121. Wijesuriya SD, Bristow J, Miller WL. Localization and analysis of the principal promoter for human tenascin-X. Genomics 2002; 80:443-52; http://dx.doi.org/10.1006/geno.2002.6852
122. Kato A, Endo T, Abiko S, Ariga H, Matsumoto K. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. Exp Cell Res 2008; 314:2661-73; http://dx.doi.org/10.1016/j.yexcr.2008.05.019
123. Endo T, Ariga H, Matsumoto K. Truncated form of tenascin-X, XB-S, interacts with mitotic motor kinesin Eg5. Mol Cell Biochem 2009; 320:53-66; http://dx.doi.org/10.1007/s11010-008-9898-y
124. Minamitani T, Ariga H, Matsumoto K. Transcription factor Sp1 activates the expression of the mouse tenascin-X gene. Biochem Biophys Res Commun 2000; 267:626-31; http://dx.doi.org/10.1006/bbrc.1999.2006
125. Gbadegesin RA, Brophy PD, Adeyemo A, Hall G, Gupta IR, Hains D, Bartkowiak B, Rabinovich CE, Chandrasekharappa S, Homstad A, et al. TNXB mutations can cause vesicoureteral reflux. J Am Soc Nephrol 2013; 24:1313-22; http://dx.doi.org/10.1681/ASN.2012121148
126. Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 2002; 30:421-5; http://dx.doi.org/10.1038/ng850
127. Lethias C, Carisey A, Comte J, Cluzel C, Exposito JY. A model of tenascin-X integration within the collagenous network. FEBS Lett 2006; 580:6281-5; http://dx.doi.org/10.1016/j.febslet.2006.10.037
128. Veit G, Hansen U, Keene DR, Bruckner P, Chiquet-Ehrismann R, Chiquet M, Koch M. Collagen XII interacts with avian tenascin-X through its NC3 domain. J Biol Chem 2006; 281:27461-70; http://dx.doi.org/10.1074/jbc.M603147200
129. Minamitani T, Ikuta T, Saito Y, Takebe G, Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H, et al. Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Exp Cell Res 2004; 298:305-15; http://dx.doi.org/10.1016/j.yexcr.2004.04.030
130. Burch GH, Bedolli MA, McDonough S, Rosenthal SM, Bristow J. Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development. Dev Dyn 1995; 203:491-504; http://dx.doi.org/10.1002/aja.1002030411
131. Geffrotin C, Garrido JJ, Tremet L, Vaiman M. Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts. Eur J Biochem 1995; 231: 83-92; http://dx.doi.org/10.1111/j.1432-1033.1995.0083f.x
132. Sakai T, Furukawa Y, Chiquet-Ehrismann R, Nakamura M, Kitagawa S, Ikemura T, Matsumoto K. Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts. J Cell Sci 1996; 109 (Pt 8):2069-77
133. Geffrotin C, Horak V, Crechet F, Tricaud Y, Lethias C, Vincent-Naulleau S, Vielh P. Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma. Biochim Biophys Acta 2000; 1524:196-202; http://dx.doi.org/10.1016/S0304-4165(00)00158-6
134. Yuan Y, Nymoen DA, Stavnes HT, Rosnes AK, Bjorang O, Wu C, Nesland JM, Davidson B. Tenascin-X is a novel diagnostic marker of malignant mesothelioma. Am J Surg Pathol 2009; 33:1673-82; http://dx.doi.org/10.1097/PAS.0b013e3181b6bde3
135. Weber P, Montag D, Schachner M, Bernhardt RR. Zebrafish tenascin-W, a new member of the tenascin family. J Neurobiol 1998; 35:1-16; http://dx.doi.org/10.1002/(SICI)1097-4695(199804)35:1%3c1::AID-NEU1%3e3.0.CO;2-9
136. Scherberich A, Tucker RP, Samandari E, Brown-Luedi M, Martin D, Chiquet-Ehrismann R.Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J Cell Sci 2004; 117:571-81; http://dx.doi.org/10.1242/jcs.00867
137. Neidhardt J, Fehr S, Kutsche M, Lohler J, Schachner M. Tenascin-N: characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants. Mol Cell Neurosci 2003; 23:193-209; http://dx.doi.org/10.1016/S1044-7431(03)00012-5
138. Degen M, Brellier F, Kain R, Ruiz C, Terracciano L, Orend G, Chiquet-Ehrismann R. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res 2007; 67:9169-79; http://dx.doi.org/10.1158/0008-5472.CAN-07-0666
139. Tucker RP, Drabikowski K, Hess JF, Ferralli J, Chiquet-Ehrismann R, Adams JC. Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol Biol 2006; 6:60; http://dx.doi.org/10.1186/1471-2148-6-60
140. Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R, Tucker RP. Avian tenascin-W: expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro. Dev Dyn 2006; 235:1532-42; http://dx.doi.org/10.1002/dvdy.20731
141. Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R, Tucker RP. Effects of tenascin-W on osteoblasts in vitro. Cell Tissue Res 2008; 334:445-55; http://dx.doi.org/10.1007/s00441-008-0715-4
142. Tucker RP, Ferralli J, Schittny JC, Chiquet-Ehrismann R. Tenascin-C and tenascin-W in whisker follicle stem cell niches: possible roles in regulating stem cell proliferation and migration. J Cell Sci 2013; 126:5111-5; http://dx.doi.org/10.1242/jcs.134650
143. Degen M, Brellier F, Schenk S, Driscoll R, Zaman K, Stupp R, Tornillo L, Terracciano L, Chiquet-Ehrismann R, Rüegg C, et al. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients. Int J Cancer 2008; 122:2454-61; http://dx.doi.org/10.1002/ijc.23417
144. Martina E, Degen M, Ruegg C, Merlo A, Lino MM, Chiquet-Ehrismann R, Brellier F. Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro. FASEB J 2010; 24:778-87; http://dx.doi.org/10.1096/fj.09-140491
145. Kimura H, Akiyama H, Nakamura T, de Crombrugghe B. Tenascin-W inhibits proliferation and differentiation of preosteoblasts during endochondral bone formation. Biochem Biophys Res Commun 2007; 356:935-41; http://dx.doi.org/10.1016/j.bbrc.2007.03.071
146. Mikura A, Okuhara S, Saito M, Ota M, Ueda K, Iseki S. Association of tenascin-W expression with mineralization in mouse calvarial development. Congenit Anom (Kyoto) 2009; 49:77-84; http://dx.doi.org/10.1111/j.1741-4520.2009.00227.x
147. d’Amaro R, Scheidegger R, Blumer S, Pazera P, Katsaros C, Graf D, Chiquet M. Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. Front Physiol 2012; 3:377
148. Morgan JM, Wong A, Yellowley CE, Genetos DC. Regulation of tenascin expression in bone. J Cell Biochem 2011; 112:3354-63; http://dx.doi.org/10.1002/jcb.23265
149. Oskarsson T, Massague J. Extracellular matrix players in metastatic niches. EMBO J 2012; 31:254-6; http://dx.doi.org/10.1038/emboj.2011.469
150. Aloj L, D’Ambrosio L, Aurilio M, Morisco A, Frigeri F, Caraco C, Di Gennaro F, Capobianco G, Giovannoni L, Menssen HD, et al. Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 2014; 41:867-77; http://dx.doi.org/10.1007/s00259-013-2658-6